You are here

Abivax

The big Covid-19 trials still to report

The big Covid-19 trials still to report

EP Vantage

clinical trials

Flag link:

Abivax Bolstered by Positive Mid-Stage Results from Ulcerative Colitis Treatment

Abivax Bolstered by Positive Mid-Stage Results from Ulcerative Colitis Treatment

BioSpace

ulcerative colitis

Flag link:

Positive momentum for French biotech industry continues: Abivax announces positive Phase II results (HIV)

Positive momentum for French biotech industry continues: Abivax announces positive Phase II results (HIV)

GoinPharma

Flag link:

Abivax up on mixed HIV data

Abivax up on mixed HIV data

Biopharma Dive

Flag link:

Abivax May List on Nasdaq After U.S. Lifts Cuba Embargo

Abivax May List on Nasdaq After U.S. Lifts Cuba Embargo

Bloomberg

Flag link:

Abivax tees up a $49M IPO to get its hep B shot into Phase III

Abivax tees up a $49M IPO to get its hep B shot into Phase III

Fierce Biotech

Flag link: